Loading clinical trials...
Loading clinical trials...
Allogeneic hematopoietic stem cell transplant (HSCT) recipients are at risk of various bacterial infections, especially due to a progressive decrease of specific antibodies. Around 90% of HSCT recipie...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT07425782 · Acute Myeloid Leukemia, Consolidation Therapy, and more
NCT03000244 · Hematopoietic Stem Cell Transplantation, Tissue Donors
NCT07569055 · Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT06665100 · Hematologic Malignancies, Hematopoietic Stem Cell Transplant (HSCT)
NCT06861257 · Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, and more
Henri-Mondor Hospital
Créteil, Val De Marne
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions